Discover the groundbreaking potential of Sglt Two inhibitors as James explains how these diabetic drugs not only lower sugar levels but also improve cardiovascular prognosis, reduce heart failure, and even benefit those without diabetes. Prepare to be amazed by the surprising findings and potential mechanisms of action discussed in this episode.
